Seeyond increased its holdings in Johnson & Johnson (NYSE:JNJ) by 0.4% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,532 shares of the company’s stock after purchasing an additional 65 shares during the period. Seeyond’s holdings in Johnson & Johnson were worth $2,394,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of JNJ. OLD Mission Capital LLC bought a new stake in Johnson & Johnson during the 3rd quarter valued at $362,000. Lehman & Derafelo Financial Resources LLC raised its holdings in Johnson & Johnson by 3.8% during the 1st quarter. Lehman & Derafelo Financial Resources LLC now owns 15,728 shares of the company’s stock valued at $2,585,000 after buying an additional 578 shares during the last quarter. Ironwood Wealth Management LLC. raised its holdings in Johnson & Johnson by 37.3% during the 1st quarter. Ironwood Wealth Management LLC. now owns 10,161 shares of the company’s stock valued at $1,670,000 after buying an additional 2,761 shares during the last quarter. E Fund Management Co. Ltd. bought a new stake in Johnson & Johnson during the 1st quarter valued at $860,000. Finally, Essex Investment Management Co. LLC raised its holdings in Johnson & Johnson by 1,903.1% during the 1st quarter. Essex Investment Management Co. LLC now owns 9,635 shares of the company’s stock valued at $1,584,000 after buying an additional 9,154 shares during the last quarter. Institutional investors own 67.29% of the company’s stock.
Shares of NYSE JNJ traded up $0.99 during trading on Thursday, reaching $160.19. 26,931 shares of the company traded hands, compared to its average volume of 7,040,690. The firm has a 50 day simple moving average of $168.96 and a 200-day simple moving average of $167.54. The company has a quick ratio of 1.13, a current ratio of 1.39 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $421.70 billion, a PE ratio of 23.94, a P/E/G ratio of 2.23 and a beta of 0.71. Johnson & Johnson has a 52-week low of $133.65 and a 52-week high of $179.92.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 7th. Stockholders of record on Tuesday, August 24th were issued a dividend of $1.06 per share. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.65%. The ex-dividend date of this dividend was Monday, August 23rd. Johnson & Johnson’s payout ratio is presently 52.80%.
JNJ has been the subject of several research reports. Morgan Stanley lowered shares of Johnson & Johnson from an “overweight” rating to an “equal weight” rating and set a $187.00 price objective for the company. in a report on Tuesday, September 7th. Wells Fargo & Company restated a “buy” rating on shares of Johnson & Johnson in a report on Thursday, October 7th. Finally, SVB Leerink restated a “buy” rating on shares of Johnson & Johnson in a report on Thursday, July 29th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $190.38.
About Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health, and wound care markets.
Further Reading: What is the Stochastic Momentum Index (SMI)?
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.